Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Brockmann

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 11, 2012
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantationMarkus Guba, Johann Pratschke, Christian Hugo, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|June 29, 2019
ABO incompatible kidney transplantation: the Saudi experienceTariq Ali, Dieter Broering, Hassan Aleid, et al.
Transplantation|May 14, 2010
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trialMarkus Guba, Johann Pratschke, Christian Hugo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96)Peter Koch, Andreas Probst, Wolfgang E Berdel, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
Transplantation|November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 TrialEdward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 11, 2012
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantationMarkus Guba, Johann Pratschke, Christian Hugo, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|June 29, 2019
ABO incompatible kidney transplantation: the Saudi experienceTariq Ali, Dieter Broering, Hassan Aleid, et al.
Transplantation|May 14, 2010
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trialMarkus Guba, Johann Pratschke, Christian Hugo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96)Peter Koch, Andreas Probst, Wolfgang E Berdel, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
Transplantation|November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 TrialEdward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Pageof 3